Back
Citius Pharmaceuticals 10K Form
Sell
34
CTXR
Citius Pharmaceuticals
Last Price:
$4.34
Seasonality Move:
26.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTXR News And Ratings
See the #1 stock for the next 7 days that we like better than CTXR
CTXR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-5.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.67 |
| Price / Book: | 0.43 |
Profitability
| EPS (TTM): | -5.97000 |
|---|---|
| Net Income (TTM): | $-39.1M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Citius Pharmaceuticals Earnings Forecast
Key Citius Pharmaceuticals Financial Ratios
-
The Interest Expense is 0.00% of Operating Income.
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Citius Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CTXR |
| CUSIP: | 17322U |
| Website: | citiuspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 1.56 |
CTXR Technical Analysis vs Fundamental Analysis
Sell
34
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a SellThe current Citius Pharmaceuticals [CTXR] share price is $3.91. The Score for CTXR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.